BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 19, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
May 5, 2010
View Archived Issues
Oxford Immunotec Raises $26M to Boost T-Cell Tests Worldwide
LONDON - Oxford Immunotec Ltd. raised $26 million in a fourth-round funding, which it said will enable it to increase sales of its T-cell diagnostic for tuberculosis and take the company through to profitability. (BioWorld International)
Read More
Asian Pacific Biotechs Branch Out from Health to White Tech
Read More
Study Pinpoints Viral RNA Targets for Future Drugs
Read More
Huntington's Drug Snagged on Statistics; Another Trial Needed?
Read More
BIO in Chicago: BioWorld Waxes Nostalgic, Biotech Perseveres
Read More
Affimed Plans to Take Antibodies into Clinic with $26M Series C
Read More
Protox's $75M Kissei Deal May Set Stage for Larger Alliances
Read More
Pluristem's Placenta-Derived Cell Therapy Yields Strong Early Data
Read More
Other News To Note
Read More